B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expression in B-C
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters
β Scribed by Negrini, M.; Cutrona, G.; Bassi, C.; Fabris, S.; Zagatti, B.; Colombo, M.; Ferracin, M.; D'Abundo, L.; Saccenti, E.; Matis, S.; Lionetti, M.; Agnelli, L.; Gentile, M.; Recchia, A. G.; Bossio, S.; Reverberi, D.; Rigolin, G.; Calin, G. A.; Sabbioni, S.; Russo, G.; Tassone, P.; Morabito, F.; Ferrarini, M.; Neri, A.
- Book ID
- 124098682
- Publisher
- American Association for Cancer Research
- Year
- 2014
- Tongue
- English
- Weight
- 731 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1078-0432
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Acute myeloid leukemia (AML) is a malignant disease of hematopoietic cells whose emergence, course, and prognosis is affected by specific recurrent genetic alterations like chromosome aberrations and point mutations, as well as by changes in the expression of certain genes. In the past